Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Trial Type:  Supportive care
Trial Status:  Active
Sponsor of Trial:  NCI
Results 1-25 of 212 for your search:
Start Over
Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer
Phase: Phase IV
Type: Health services research, Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 4B-14-4, NCI-2015-00279, P30CA014089, NCT02438852
Acupressure for Persistent Cancer Related Fatigue
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: CA151445, R01CA151445, NCT01281904
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: N0574, NCCTG-N0574, ACOSOG-N0574, CDR0000499633, NCI-2009-00653, NCT00377156
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000629591, GOG-0249, NCT00807768
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0920, CDR0000651536, NCI-2011-00878, NCT00956007
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000654697, ECOG-E3F05, E3F05, NCT00978458
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0724, CDR0000654709, NCI-2011-01973, NCT00980954
Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2010-0547 MDA, MDA-04-01, CDR0000674208, 2010-0547, NCI-2011-02073, U10, NCT01141231
Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 1 to < 10
Sponsor: NCI, Other
Protocol IDs: AALL0932, NCI-2011-02599, CDR0000683227, U10CA098543, COG-AALL0932, NCT01190930
Relaxation for Women With Breast Cancer Undergoing Radiotherapy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2009-0976, NCI-2012-01895, 2T32CA009666-21, NCT01202851
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2448.00, NCI-2010-02035, P01CA018029, P30CA015704, NCT01231412
Xerostomia Acupuncture Trial
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2010-0584, NCI-2011-00306, R01CA148707-01A1, NCT01266044
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Status: Active
Age: 6 months to 21 years
Sponsor: NCI, Other
Protocol IDs: ACCL0934, NCI-2011-02636, CDR0000695661, COG-ACCL0934, U10CA095861, NCT01371656
Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 3 months to 30 years
Sponsor: NCI, Other
Protocol IDs: ACCL0933, NCI-2011-02640, CDR0000695748, COG-ACCL0933, U10CA095861, NCT01307579
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 4 to 18
Sponsor: NCI, Other
Protocol IDs: SCUSF 1202, Previously COG-ACCL1032, 5U10CA081920, COG-ACCL1032, ACCL1032, NCT01346267
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ANZGOG-0902/GOG-0274/RTOG-1174, NCI-2011-02978, CDR0000706698, GOG-0274, RTOG-1174, ANZGOG-0902, ANZGOG-0902-GOG-0274, U10CA027469, NCT01414608
Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy
Phase: Phase III
Type: Supportive care, Tissue collection/Repository, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000716291, NCCTG-N10CB, N10CB, NCT01473290
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Phase: Phase III
Type: Supportive care
Status: Active
Age: 3 months to 20 years
Sponsor: NCI, Other
Protocol IDs: ACCL1131, NCI-2012-00102, CDR0000721415, COG-ACCL1131, U10CA095861, NCT01503515
S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: S1200, R01AT000636-01, U10CA037429, NCI-2012-00251, SWOG-S1200, NCT01535066
CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000727295, NCCTG-N11C5, N11C5, NCT01545687
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: A221102, CDR0000730083, NCI-2012-00719, U10CA037447, CALGB-A221102, NCCTG-N10C7, NCT01573442
S1202: Duloxetine Hydrochloride to Treat Muscle, Bone, and Joint Pain in Pts W/Early-Stage Breast Cancer Receiving Hormone Therapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: S1202, U10CA037429, NCI-2012-01960, SWOG-S1202, NCT01598298
INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2605.00, NCI-2012-00743, R01CA160684, P30CA015704, NCT01602211
Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate Cancer
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11113, NCI-2012-00558, NCT01613651
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11-497, NCT01617161
Start Over